Cetrotide

GPTKB entity

Properties (53)
Predicate Object
gptkbp:instanceOf medication
gptkbp:activeDuring cetrorelix
gptkbp:approves gptkb:FDA
gptkbp:availability prescription only
gptkbp:brand gptkb:Cetrotide
gptkbp:clinicalTrials Phase III
assisted reproductive technology
investigating long-term effects
consult with fertility specialists
fertility treatment protocols
follow reproductive endocrinology standards
reduces risk of ovarian hyperstimulation syndrome
improves_IVF_success_rates
gptkbp:contraindication rarely severe
hypersensitivity_to_cetrorelix
gptkbp:dosageForm injection
based on individual response
gptkbp:drugInterdiction available
none significant
competitive antagonist of GnRH receptors
gonadotropin-releasing hormone antagonist
predictable absorption
gptkbp:endOfLife approximately 2.5 hours
gptkbp:formulation solution for injection
gptkbp:hasCapacity available through healthcare providers
gptkbp:hasPopulation women undergoing IVF
gptkbp:healthcare monitor for allergic reactions
injection technique training
https://www.w3.org/2000/01/rdf-schema#label Cetrotide
gptkbp:impact up to 5 days
successful ovulation induction
gptkbp:inheritsFrom within 24 hours
gptkbp:issuedBy subcutaneous injection
gptkbp:mandates controlled ovarian stimulation
gptkbp:manufacturer Merck Serono
gptkbp:marketedAs multiple countries
gptkbp:nutritionalValue liver
gptkbp:offers varies by region
gptkbp:packaging vial
gptkbp:regulatoryCompliance approved for use in fertility treatments
gptkbp:researchFocus fertility preservation
gptkbp:researchInterest ongoing
gptkbp:route subcutaneous
gptkbp:safetyFeatures generally well tolerated
recommended during treatment
gptkbp:sideEffect headache
nausea
injection site reactions
gptkbp:storage refrigerated
gptkbp:supplyChain managed by pharmaceutical distributors
gptkbp:triggerType inhibits gonadotropin release
gptkbp:usedFor prevent premature ovulation
gptkbp:waterManagement urine